Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of OATP1B inhibition on sorafenib metabolism with rifampicin in adult cancer patients
2013-001525-10Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sorafenib in cancer, sponsored by Erasmus MC. Primary endpoints: Sorafenib plasma levels with and without rifampicin and Sorafenib metabolite plasma levels with and without rifampicin. Started Apr 2013; status: completed.
02
Drugs
sorafenib
03
Conditions
cancer
Beyond the preview
Go deeper on 2013-001525-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001525-10.